# Braze, Inc.: filings

BRZE · Nasdaq · CIK 1676238 · [Technology](/sectors/technology.md) · fiscal year ends Jan 31

Pages: [Overview](/companies/brze.md) · [Financials](/companies/brze/financials.md) · [Filings](/companies/brze/filings.md) · [Insiders](/companies/brze/insiders.md)

## Reports and events: 62 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 440, 144 95, 8-K 34, 3 28, SC 13G/A 22, SCHEDULE 13G/A 21, SC 13G 18, 10-Q 15, DEFA14A 8, S-8 8, 4/A 6, 10-K 5, DEF 14A 5, SCHEDULE 13G 5, UPLOAD 5, ARS 4, CORRESP 4, D 4, DRS/A 2, DRSLTR 2, S-3ASR 2, 424B4 1, 5 1, 8-A12B 1, 8-K/A 1, CERT 1, DRS 1, EFFECT 1, PRE 14A 1, S-1 1, S-1/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-20 | 09:11 ET | [8-K](/filings/0000950103-26-015850.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950103-26-015850 |
| 2026-09-09 | 17:40 ET | [10-Q](/filings/0001676238-26-000040.md) | Quarterly report, period 2026-07-31 | 0001676238-26-000040 |
| 2026-09-08 | 16:07 ET | [8-K](/filings/0001676238-26-000039.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001676238-26-000039 |
| 2026-07-02 | 16:45 ET | [8-K](/filings/0001676238-26-000033.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001676238-26-000033 |
| 2026-05-28 | 17:47 ET | [10-Q](/filings/0001676238-26-000027.md) | Quarterly report, period 2026-04-30 | 0001676238-26-000027 |
| 2026-05-27 | 16:09 ET | [8-K](/filings/0001676238-26-000024.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001676238-26-000024 |
| 2026-05-18 | 16:30 ET | [DEF 14A](/filings/0001140361-26-021908.md) | Proxy statement, period 2026-06-30 | 0001140361-26-021908 |
| 2026-04-28 | 08:11 ET | [8-K](/filings/0000950103-26-006243.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950103-26-006243 |
| 2026-04-07 | 09:00 ET | [8-K](/filings/0001676238-26-000016.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001676238-26-000016 |
| 2026-03-25 | 17:52 ET | [10-K](/filings/0001676238-26-000013.md) | Annual report, period 2026-01-31 | 0001676238-26-000013 |
| 2026-03-24 | 16:06 ET | [8-K](/filings/0001676238-26-000011.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001676238-26-000011 |
| 2026-02-02 | 08:00 ET | [8-K](/filings/0001676238-26-000006.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001676238-26-000006 |
| 2025-12-10 | 17:42 ET | [10-Q](/filings/0001676238-25-000147.md) | Quarterly report, period 2025-10-31 | 0001676238-25-000147 |
| 2025-12-09 | 16:05 ET | [8-K](/filings/0001676238-25-000145.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001676238-25-000145 |
| 2025-09-05 | 17:39 ET | [10-Q](/filings/0001676238-25-000134.md) | Quarterly report, period 2025-07-31 | 0001676238-25-000134 |
| 2025-09-04 | 16:10 ET | [8-K](/filings/0001676238-25-000132.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001676238-25-000132 |
| 2025-06-27 | 16:06 ET | [8-K](/filings/0001676238-25-000088.md) | 5.07 Shareholder vote results | 0001676238-25-000088 |
| 2025-06-06 | 17:54 ET | [10-Q](/filings/0001676238-25-000079.md) | Quarterly report, period 2025-04-30 | 0001676238-25-000079 |
| 2025-06-05 | 16:14 ET | [8-K](/filings/0001676238-25-000077.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001676238-25-000077 |
| 2025-05-15 | 16:05 ET | [DEF 14A](/filings/0001140361-25-019268.md) | Proxy statement, period 2025-06-26 | 0001140361-25-019268 |
| 2025-03-31 | 07:25 ET | [10-K](/filings/0001676238-25-000054.md) | Annual report, period 2025-01-31 | 0001676238-25-000054 |
| 2025-03-27 | 16:22 ET | [8-K](/filings/0001676238-25-000051.md) | 2.02 Results of operations; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001676238-25-000051 |
| 2025-02-03 | 08:37 ET | [8-K](/filings/0001676238-25-000015.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001676238-25-000015 |
| 2024-12-10 | 17:42 ET | [10-Q](/filings/0001676238-24-000208.md) | Quarterly report, period 2024-10-31 | 0001676238-24-000208 |
| 2024-12-09 | 16:06 ET | [8-K](/filings/0001676238-24-000206.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001676238-24-000206 |
| 2024-09-06 | 17:45 ET | [10-Q](/filings/0001676238-24-000171.md) | Quarterly report, period 2024-07-31 | 0001676238-24-000171 |
| 2024-09-05 | 16:06 ET | [8-K](/filings/0001676238-24-000169.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001676238-24-000169 |
| 2024-07-02 | 16:29 ET | [8-K](/filings/0001676238-24-000127.md) | 5.07 Shareholder vote results | 0001676238-24-000127 |
| 2024-06-07 | 17:42 ET | [10-Q](/filings/0001676238-24-000103.md) | Quarterly report, period 2024-04-30 | 0001676238-24-000103 |
| 2024-06-06 | 16:07 ET | [8-K](/filings/0001676238-24-000101.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001676238-24-000101 |
| 2024-06-03 | 16:22 ET | [8-K](/filings/0001676238-24-000087.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001676238-24-000087 |
| 2024-05-14 | 16:16 ET | [DEF 14A](/filings/0001140361-24-025963.md) | Proxy statement, period 2024-06-27 | 0001140361-24-025963 |
| 2024-04-01 | 06:10 ET | [10-K](/filings/0001676238-24-000049.md) | Annual report, period 2024-01-31 | 0001676238-24-000049 |
| 2024-03-27 | 16:09 ET | [8-K](/filings/0001676238-24-000047.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001676238-24-000047 |
| 2023-12-07 | 17:47 ET | [10-Q](/filings/0001676238-23-000209.md) | Quarterly report, period 2023-10-31 | 0001676238-23-000209 |
| 2023-12-06 | 16:11 ET | [8-K](/filings/0001676238-23-000207.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001676238-23-000207 |
| 2023-09-08 | 17:43 ET | [10-Q](/filings/0001676238-23-000145.md) | Quarterly report, period 2023-07-31 | 0001676238-23-000145 |
| 2023-09-07 | 16:07 ET | [8-K](/filings/0001676238-23-000142.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001676238-23-000142 |
| 2023-07-05 | 16:32 ET | [8-K](/filings/0001676238-23-000083.md) | 5.07 Shareholder vote results | 0001676238-23-000083 |
| 2023-06-09 | 18:13 ET | [10-Q](/filings/0001676238-23-000068.md) | Quarterly report, period 2023-04-30 | 0001676238-23-000068 |
| 2023-06-08 | 16:12 ET | [8-K](/filings/0001676238-23-000065.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001676238-23-000065 |
| 2023-05-17 | 16:16 ET | [DEF 14A](/filings/0001140361-23-025261.md) | Proxy statement | 0001140361-23-025261 |
| 2023-04-05 | 19:19 ET | [8-K/A](/filings/0001676238-23-000039.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001676238-23-000039 |
| 2023-04-04 | 09:06 ET | [8-K](/filings/0001676238-23-000036.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001676238-23-000036 |
| 2023-03-31 | 19:27 ET | [10-K](/filings/0001676238-23-000031.md) | Annual report, period 2023-01-31 | 0001676238-23-000031 |
| 2023-03-30 | 16:09 ET | [8-K](/filings/0001676238-23-000028.md) | 2.02 Results of operations | 0001676238-23-000028 |
| 2022-12-14 | 18:14 ET | [10-Q](/filings/0001676238-22-000065.md) | Quarterly report, period 2022-10-31 | 0001676238-22-000065 |
| 2022-12-13 | 16:07 ET | [8-K](/filings/0001676238-22-000063.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001676238-22-000063 |
| 2022-11-23 | 16:25 ET | [8-K](/filings/0001676238-22-000052.md) | 1.01 Entry into a material agreement | 0001676238-22-000052 |
| 2022-09-13 | 18:18 ET | [10-Q](/filings/0001676238-22-000047.md) | Quarterly report, period 2022-07-31 | 0001676238-22-000047 |

Page 1 of 2. [Older](/companies/brze/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 13:39 ET. No prices; not investment advice.